Phase I/II Study of PCI-24781 in Combination With Doxorubicin for Treatment of Advanced Sarcomas Following Failure or Prior Anthracycline Therapy
Phase of Trial: Phase I/II
Latest Information Update: 16 Feb 2017
At a glance
- Drugs Abexinostat (Primary) ; Doxorubicin
- Indications Sarcoma
- Focus Adverse reactions; Therapeutic Use
- 02 Mar 2016 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 26 Mar 2014 Planned End Date changed from 1 Dec 2013 to 1 Dec 2015 as reported by ClinicalTrials.gov record.
- 05 Dec 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.